Literature DB >> 10751548

Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions.

C E Maher1, D E Selley, S R Childers.   

Abstract

This study investigated the relationship between mu receptor binding and mu agonist activation of G-proteins in the rat brain. To directly compare agonist potencies in receptor binding (K(i) values) and G-protein activation (K(s) values), both agonist-stimulated [(35)S]guanosine-5'-O-(gamma-thio)-triphosphate ([(35)S]GTPgammaS) and [(3)H]naloxone binding assays were conducted under identical conditions, using the full mu agonist [d-Ala(2), N-Me(4), Gly(5)-ol]-enkephalin (DAMGO). DAMGO exhibited biphasic competition of [(3)H]naloxone binding and stimulation of [(35)S]GTPgammaS binding in most regions. Whereas the high-affinity component represented a large percentage (50-80%) of total receptor sites, the high-affinity component of DAMGO-stimulated [(35)S]GTPgammaS binding was much lower, <30% of the total, and in most regions significant stimulation of [(35)S]GTPgammaS binding did not occur until the high-affinity binding sites were completely occupied. Moreover, the low-affinity potencies for DAMGO in receptor binding and G-protein activation were the same across different regions. Receptor-transducer amplification factors were calculated by the ratio of the apparent B(max) of net agonist-stimulated [(35)S]GTPgammaS binding to the B(max) of receptor binding. Amplification factors for the nine regions examined were relatively high and varied significantly across regions, from a ratio of 8 in the thalamus to 38 in the cortex, suggesting that the efficiency of mu opioid receptor coupling to G-proteins varies across brain regions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751548     DOI: 10.1016/s0006-2952(00)00272-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.

Authors:  Katharine M Seip-Cammack; Brian Reed; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2012-07-25       Impact factor: 4.530

2.  Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.

Authors:  L J Sim-Selley; D E Selley; L J Vogt; S R Childers; T J Martin
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

3.  Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells.

Authors:  Peng Huang; Wei Xu; Su-In Yoon; Chongguang Chen; Parkson Lee-Gau Chong; Ellen M Unterwald; Lee-Yuan Liu-Chen
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

4.  Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesia.

Authors:  Jörn Lötsch; Carsten Skarke; Jutta Darimont; Michael Zimmermann; Lutz Bräutigam; Gerd Geisslinger; Alfred Ultsch; Bruno G Oertel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-18       Impact factor: 3.000

5.  The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.

Authors:  Hong Xie; James H Woods; John R Traynor; Mei-Chuan Ko
Journal:  Anesth Analg       Date:  2008-06       Impact factor: 5.108

6.  Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.

Authors:  Huina Zhang; Mary M Torregrossa; Emily M Jutkiewicz; Yong-Gong Shi; Kenner C Rice; James H Woods; Stanley J Watson; M C Ko
Journal:  Eur J Neurosci       Date:  2006-02       Impact factor: 3.386

7.  GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4.

Authors:  Silvia Burbassi; Vincent J Aloyo; Kenny J Simansky; Olimpia Meucci
Journal:  J Neuroimmune Pharmacol       Date:  2007-10-25       Impact factor: 4.147

8.  Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.

Authors:  Yun K Hahn; Jason J Paris; Aron H Lichtman; Kurt F Hauser; Laura J Sim-Selley; Dana E Selley; Pamela E Knapp
Journal:  Neurobiol Dis       Date:  2016-02-01       Impact factor: 5.996

9.  Alterations in the Proteome and Phosphoproteome Profiles of Rat Hippocampus after Six Months of Morphine Withdrawal: Comparison with the Forebrain Cortex.

Authors:  Hana Ujcikova; Adam Eckhardt; Lucie Hejnova; Jiri Novotny; Petr Svoboda
Journal:  Biomedicines       Date:  2021-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.